Prosztatarák: vizsgálatok itt: Kanada
129 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in KanadaADT De-escalation in Selected High-Risk Prostate Cancer Patients (ADaPPt Trial) a GROUQ Led PCS Study (PCS XIV)
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 600
- Run by
- Dr. Tamim Niazi
See details and how to joinNCT07777263 - 2. fázisTaking peopleGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- Where
- London, Ottawa, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 315 worldwide
- Run by
- University of British Columbia
See details and how to joinNCT04812366 - No phaseTaking peopleContinence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer
- Where
- Edmonton
- Életkor
- 18 év and over
- People
- 106
- Run by
- University of Alberta
See details and how to joinNCT06072911 - 1. fázisNot yet taking people in KanadaA Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Where
- Montreal, Toronto
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06067841 · EU 2024-513987-24-00 - No phaseNot yet taking people in Kanada68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 8
- Run by
- University Health Network, Toronto
See details and how to joinNCT07747493 - No phaseNot yet taking people in KanadaMICRO-ultrasound Guided Prostate SBRT
- Where
- London
- Életkor
- 18 év and over
- People
- 112
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT07737457 - 2. fázisTaking peopleDuration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
- Where
- Toronto
- Életkor
- 18 év to 100 év
- People
- 352
- Run by
- University Health Network, Toronto
See details and how to joinNCT05404139 - No phaseCsak meghívásosClinical Utility of ClarityDX Prostate
- Where
- Calgary, Edmonton, Toronto, Vancouver, Winnipeg
- Életkor
- 18 év and over
- People
- 1450
- Run by
- Nanostics
See details and how to joinNCT06678828 - 3. fázisTaking peopleThe Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
- Where
- Burnaby, Toronto
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- Telix Pharmaceuticals (Innovations) Pty Limited
See details and how to joinNCT06520345 - 4. fázisTaking peopleEvaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
- Where
- Kitchener, Ottawa, Saskatoon
- Életkor
- 18 év and over
- People
- 50
- Run by
- Ottawa Hospital Research Institute
See details and how to joinNCT07252726 - 3. fázisTaking peopleDocetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Where
- Edmonton, Greater Sudbury, Greenfield Park, Hamilton, Kingston, Kitchener, London, Mississauga, Montreal, Ottawa, Québec, Saint Catharines, Saint John, Saskatoon, Toronto, Vancouver, Winnipeg
- Életkor
- 18 év and over
- People
- 830 worldwide
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT06592924 - 1. fázisTaking peopleFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Edmonton, Hamilton, Montreal, Sherbrooke, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 198 worldwide
- Run by
- Bayer
See details and how to joinNCT06217822 · EU 2023-507486-26-00 - 2. fázisTaking peopleStereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer
- Where
- Toronto
- Életkor
- 18 év to 100 év
- People
- 75
- Run by
- University Health Network, Toronto
See details and how to joinNCT06927635 - No phaseTaking peopleNon-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
- Where
- Gatineau, Montreal, Québec
- Életkor
- 18 év and over
- People
- 434
- Run by
- CHU de Quebec-Universite Laval
See details and how to joinNCT07483658 - No phaseTaking peoplePartial Prostate Salvage High Dose Rate Brachytherapy
- Where
- Kelowna
- Életkor
- 45 év and over
- People
- 30
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT03246802 - 2. fázisTaking peopleA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Kelowna, Montreal, Toronto
- Életkor
- 18 év and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - 2. fázisTaking peoplePhase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer
- Where
- Surrey, Victoria
- Életkor
- 18 év and over
- People
- 100
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT06835725 - No phaseTaking peopleHigh-Dose-Rate Brachytherapy
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 500
- Run by
- University Health Network, Toronto
See details and how to joinNCT00913939 - No phaseTaking peopleA SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 376
- Run by
- St. Mary's Research Center, Canada
See details and how to joinNCT06363266 - No phaseTaking peopleA Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer
- Where
- Toronto
- Életkor
- 50 év and over
- People
- 100
- Run by
- University Health Network, Toronto
See details and how to joinNCT06451445 - No phaseTaking peopleMarathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Where
- Kingston, Ottawa, Toronto
- Életkor
- 18 év and over
- People
- 500
- Run by
- University Health Network, Toronto
See details and how to joinNCT05403177 - 1. fázisTaking peopleStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- Where
- Montreal, Toronto
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- Senhwa Biosciences, Inc.
See details and how to joinNCT04890613 - No phaseTaking peopleMRI Guided Focal Laser Ablation of Prostate Cancer
- Where
- Toronto
- Életkor
- 40 év to 80 év
- People
- 102
- Run by
- University Health Network, Toronto
See details and how to joinNCT03650595 - No phaseTaking peopleModerate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 100
- Run by
- University Health Network, Toronto
See details and how to joinNCT05313815 - 4. fázisTaking peopleLong-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Where
- Montreal
- Életkor
- 18 év to 100 év
- People
- 700 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00